Vázquez-Tsuji O, Gutiérrez CP, Campos RT, Rojas GA, Martínez-Barbabosa I, García CG

Language: Spanish
References: 13
Page: 70-77
PDF size: 47.91 Kb.

ABSTRACT

Objective: To determine the usefulness of the galactomannan antigen detection with monoclonal antibodies, direct examination and culture in the monitoring and diagnosis of nosocomial aspergillosis. Material and methods: The population studied was hospitalized children in the Instituto Nacional de Pediatria during an outbreak of nosocomial aspergillosis from october 1st, 1997 to july 31, 1998. Children, were one day to 18 years of age; both genders, with diagnosis of aspergillosis. They were divided in two groups: Group A with nosocomial aspergillosis diagnosed by laboratory tests (antigen detection, direct exam and culture) and radiodiagnosis; Group B with clinical features compatible with aspergillosis which was discharged by laboratory tests (antigen detection, direct exam and culture) and radiodiagnosis. Calculation of the sample was made according to Patterson study with a p1: 60, p2:15, pondered P of 0.365 and a pondered Q of 0.625. Sixty negative patients and 16 positive patients were included. Results: Association between fungus and clinical features were: A. flavus was present in 57.1% of pulmonary cases, A. fumigatus, A. flavus and A. niger were found in 33.3% of the sinusal aspergillosis. In the systemic and mixed forms there was no complete identification. To take on the antigen detection as a gold standard; direct examination had a sensitivity of 0.31 and a specificity of 1.0, positivity predictive value was 1.0, negative predictive value was 0.87. Culture had a sensitivity of 0.54 and a specificity of 0.97, positive predictive value was 0.78, negative predictive value was 0.91. Conclusion: Detection of galactomannan antigen with monoclonal antibodies and direct examination are the most useful tests for the diagnosis of nosocomial aspergillosis. The culture identifies the type of fungus. Based on the results of this study, other 22 cases of nosocomial aspergillosis were detected. In the present paper the mortality was 37.5% compared with 50 to 94% in other series.

REFERENCES

1. Rippon J. Tratado de Micología Médica. 3a ed. México: Interamericana McGraw-Hill 1993: 668-703.

2. Debe F. Une nouvelle forme anatomoradiologie de mycose pulmonaire primitive. Le méga-mycetome intrabronchestasique. Arch Med Chir App Respir 1988; 13: 337-9.

3. Chupan DM, Cazin J. Humoral response to experimental petriellidosis. Infect Immun 1979; 24: 843-6.

4. Yu VL, Muder RR, Porsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: results from three-year prospective study. Am J Med 1986; 81: 249-54.

5. Vázquez TO. Estrategias en la prevención de aspergilosis nosocomial. Rev Enf Infecc Pediatr 1999; 47: 193-4.

6. Patterson JF, Zidouh A, Miniter P, Andriole VT, Patterson TF. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect Control Hosp Epidemiol 1997; 18: 104-8.

7. Von Fiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341-7.

8. Aherens J, Graybill RJ, Craven CP, Taylor RL. Treatment of experimental murine candidiasis with liposome-associated amphotericin B. Sabouraudia 1984; 22: 163-4.

9. Verweij EP, Rijs AJM, De Pauw EB, Horrevorts AM, Hoogkamp-Korstanje JAA, Meiss JFGM. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995; 48: 474-6.

10. Hopwood V, Johnson ME, Foot ABM, Evans EGU, Warnock DW. Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995; 48: 210-3.

11. Warnock WD, Foot ABM, Johnson EM, Mitchell SB, Cornish JM, Oakhill AO. Aspergillus antigen latex test for diagnosis of invasive aspergillosis. Lancet 1991; 338: 1023-4.

12. Hall PJ, Farrior JB. Aspergillus mastoiditis. Otolaryngol Head Neck Surg 1993; 108: 67-70.

13. Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E. Prospective sandwich enzime-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232-7.